Pain Therapeutics (PTIE)
This is a biopharmaceutical company that develops drugs. Pain Therapeutics has four drug candidates in clinical programs, including REMOXY, abuse-resistant hydromorphone, abuse-resistant hydrocodone and a radio-labeled monoclonal antibody to treat metastatic melanoma. This stock is trading up 4.4% to $4.05 in recent trading.
Today's Range: $3.83-$4.06
52-week Range: $3.28-$9.86
Three-Month Average Volume: 173,002
Look for PTIE to sustain a move or close over those levels with volume that's near or above 173,002 shares. If we get that action soon, then PTIE could easily re-test its 2012 high of $4.53, or its next significant overhead resistance level at $4.84. Keep in mind, that PTIE will need to sustain a trend above its 200-day at $4.07 with strong volume, to give it a chance at making that larger move. To see more stocks under-$10 that are making notable moves higher today, check out the Stocks Under-$10 Moving Higher portfolio on Stockpickr. -- Written by Roberto Pedone in Winderemere, Fla.
Twitter and become a fan on Facebook. This article is commentary by an independent contributor, separate from TheStreet's regular news coverage.